Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection

View Full Size 

Download

• Thumbnail JPEG, 72x46, 2.4 KB
• Preview JPEG, 144x93, 5.4 KB
• Small JPEG, 300x194, 14.2 KB
• Full Size JPEG, 940x611, 61.3 KB